Product Images Gabapentin

The text represents a chart or table with information on pain scores. It includes a mean pain score of 10, and two periods of 4 weeks each: a dose titration period and a fixed dose period. The table also shows a comparison between a placebo group and a group that took Gabapentin at a dose of 3600 mg/day. Lastly, it includes a baseline score, but it is not possible to determine its value based on the provided text.*

This appears to be a chart or graph for a clinical study evaluating the mean pain score over a period of time in different treatment groups. The chart shows four treatment groups: placebo, gabapentin at a dose of 1800mg/day, gabapentin at a dose of 2400mg/day, and a control group labeled "Heok Dose Titration Period" and "Check Fixed Dose Period." The x-axis shows the duration of the study in weeks, and the y-axis shows the mean pain score.*

This appears to be a graphical representation of the proportion of responders (patients with a 50% reduction in pain score) in controlled PHN studies, along with some numerical percentages and study names. Not enough context is provided to understand the significance or meaning of these results.*

This is a description of a medication named Neurontin 100mg Capsule, packaged by Bryant Ranck Prepack. It contains the NDC 7133511981 and should be stored at 20°-25°C (68°-77°F). The label warns to keep all drugs out of reach of children. There is also a number listed at the bottom: 01572561523487.*